Breakthrough treatments, such as mRNA and personalized therapies, have created tremendous opportunities for pharmaceutical companies but require intricate manufacturing, supply chain and quality control processes that are difficult to support. In addition, these complex products are coming to market faster than ever, leaving less time to develop and optimize the manufacturing process.

This combination of product complexity and compressed timeframes highlights the need for a digital thread that can securely connect siloed teams and datasets. By embracing technologies like Cloud, AI and machine learning, these companies are able to deliver more personalized products faster and improve the patient experience.

AWS and Accenture are collaborating at several pharmaceutical companies to transform these processes. In this session, we will identify key learnings and patterns such as how data is being used to optimize clinical trials, accelerate products to market and expand their pipelines to become more patient-centric.

Featured Speakers

Dan Sheeran

Director
AWS Healthcare Life Sciences (HCLS) Global Vertical

Dan oversees AWS support of customers in the Life Science, Genomics and Healthcare IT sectors. Prior to AWS, Dan spent nine years as co-founder and CEO of two digital health startups: HealthSlate, a leading CDC-recognized provider of the national Diabetes Prevention Program (acquired by Brook Health); and entrée.ai, which uses natural language technology to enable consumers to track meals and look up nutrition values in food. Previously, Dan served as Senior Vice President of Music and Video at RealNetworks, where he oversaw the Rhapsody music service, RealPlayer, and RealAudio.

Dan earned an MBA from the Kellogg School at Northwestern and a B.S. from Georgetown University.

Stuart Henderson

Client Account Lead
Accenture

Stuart Henderson is Accenture's global industry lead for Life Sciences. He guides the strategies, offerings and thought leadership to help pharma, biotech, medical technology, distributor and consumer health companies reshape the future of medicine and care.

With 25+ years of experience in the pharma and biotech industry, Stuart is recognized for his insight into disruption and emerging opportunities, as well as his ability to strategize and execute change, helping companies to pivot and transform their mindsets, approaches and business models to succeed in a new era. He has helped life sciences leaders explore specialized and precision medicine, design and use medical technologies in exciting new ways, and embrace innovative technologies and partnerships to improve patient engagement and care, accelerating R&D and rapidly bringing complex solutions to market.

Stuart joined Accenture in 2014. He earned a Bachelor of Science degree in information technology from De Montfort University.

Date:  Wednesday, October 13, 2021
Time:  11am ET / 8am PT
Duration:  1 Hour

Register now for this webinar